Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
Kimmel and Disney are discussing a post-2026-27 season deal as the economics of late-night television continue to deteriorate, Variety reported.
JPMorgan cuts Chewy stock price target to $24. Here’s why analyst Doug Anmuth recommends caution when playing CHWY shares.
Uber’s CEO just said something about layoffs that nobody else cutting jobs is saying.
The e-commerce marketplace giant reported a notable insider sale as its stock has risen over the trailing 12 months.
Though Vistra has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.
UBS warns: NuScale is starting to lose the nuclear race.
Seagate just gave back a chunk of its monster year-to-date run with no news attached, and the reason Micron is doing the opposite tells you everything about where the smart money actually sits in memory right now.
Despite the sale, the CEO retains extensive direct and indirect holdings.
MLTX has faded since a mid-June rally on year-long hidradenitis suppurativa data and an August psoriatic arthritis readout, leaving the stock more than 75% below its 52-week high.
Rocket Lab (RKLB) stock fell 39% between mid-June and September 10, while the S&P 500 gained 2.4%. The stock fell 39%—about twice as far as L3Harris Technologies, down 18.9%, and far more than Lockheed Martin, down 1.3%, and Northrop Grumman, down 5.3%—suggesting company-specific headwinds compounded broader sector softness. Yet the company just posted record revenue, and the CEO counts more than $1 billion of new contracts since Q2 2026 began. None of that changed the Neutron rocket's calendar.
Disposition represented less than 1% of his direct equity stake under a pre-planned Rule 10b5-1 trading arrangement adopted in December 2025.
Shopify stock drops under a key level. Here's a spread strategy trade aimed at making a quick profit.
Ciena's 15.2% weekly slide contrasts with surging earnings and AI demand as supply, concentration and valuation risks put execution in focus.
CPI's biggest fan just decided to sell the stock. Is it time to panic?
AMGN stock fell after Novartis' Pelacarsen trial failed, though Amgen's own Olpasiran and Repatha differ in mechanism and results, and analysts have kept price targets largely intact.
Hours after an Anthropic researcher put the chance of AI killing humanity above 10%, HIVE’s Frank Holmes said the real scare is Beijing.
While market commentators kept warning of an overdue selloff, retirement savers did something unexpected with their money. The behavior gap between what investors said and what they actually did reveals a quiet structural shift in how Americans treat market volatility.
According to TheFly, UBS cut its price target on SMR stock to $6 from $10, implying a 41% downside potential from the previous close.
Anmuth sets a December 2027 target of $24 on seven times 2028 EBITDA
Morgan Stanley Cuts Novo Nordisk to Underweight as Semaglutide Risks Cloud Outlook
USA Rare Earth falls below key moving averages as losses, cash burn and production risks weigh on its outlook despite major expansion efforts.
The stock market fell as oil prices and Treasury yields soared, but rebounded Friday on the CPI inflation report. Apple, Oracle, Meta were key movers.
SOUN stock's 15% monthly slide improves its risk-reward as strong growth and OASYS momentum offset losses, cash burn and LivePerson integration risks.
Wharton professor Jeremy Siegel sees a collision coming between a new Fed chair, a bond market demanding action, and stocks caught in the crossfire at next week's FOMC meeting.
AeroVironment faces weak near-term fundamentals, premium valuation and operational risks despite revenue growth, liquidity and fresh LOCUST orders.
Morgan Stanley keeps Novo price target at 250 DKK
Florida is suing Netflix for billions, accusing the streaming giant of secretly tracking children for advertisers while publicly promising families a safe alternative to social media surveillance. The outcome could unravel the economics powering Netflix's fastest-growing business.
National Beverage stock has lots of problems right now, and no good solutions.
Two analyst downgrades in back-to-back sessions have Chewy stock cratering while the broader market climbs, and the reasoning behind both cuts points to a force that Chewy's own strong execution simply cannot overcome.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
